Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3772_Библиотеки_им_академика_М_И_Перельмана
.pdf
Index
https://t.me/medicina_free
A
Ablation, 7, 11, 23, 84, 90, 113–115, 119, 122, 133, 141,
143, 144, 149, 151, 155, 173, 181, 186, 196, 198,
244, 247
Adherence, 7, 18, 47, 61, 62, 90, 161, 171, 195, 196, 198, 217,
229–234, 237, 239, 243, 249
Afferent, 3–7, 11, 14–16, 25, 57–59, 61–66, 68, 79, 81, 91–93,
97–100, 109, 110, 127, 131, 133, 157, 172–174, 182, 184,
199
Alcohol-mediated neurolysis, 155–167
Ambulatory blood pressure measurement, 13, 16
Apnea/hypopnea index, 65, 107, 109
Arrhythmia, 7, 113, 120, 121
Atrial brillation, 57, 68, 81, 108, 113–115, 212, 249, 251
Augmentation index, 41, 67, 84, 85
Autosomal dominant polycystic kidney disease, 125–127, 136
B
Baroreceptor, 4, 60, 61, 64, 110, 193, 199–204, 244
Baroreceptor amplication, 199
Based devices, 155, 157
Biomarkers, 7, 58, 63–66, 68, 81, 171
Blood pressure, 12, 21, 37, 47, 48, 52–54, 79, 80, 90, 114, 135, 143,
157, 193, 195, 199, 202, 203, 209, 212–214, 218, 220, 221,
229, 238, 241, 243, 248
Brain-Kidney Axis, 5–7
C
Cardiovascular diseases, 60, 108
Cardiovascular events, 18, 53, 66, 68, 79, 82, 84, 99, 100, 102, 103,
107, 110, 149, 157, 204, 249
Cardiovascular risk, 47, 66, 67, 79, 80, 84, 89, 93, 97–99, 199, 212,
238, 239, 243
Carotid body, 193–198
Carotid sinus, 193, 194, 198–200, 202–204
Carotid sinus nerve, 193, 194, 198, 199, 203
Catheter ablation, 114, 115, 119–122
Chemical adherence testing, 230
Chemical neurolysis, 158, 166, 167
Chronic kidney disease, 7, 15, 16, 21, 64, 68, 80, 83, 97–98, 102, 107,
114, 126, 171, 174, 175, 202, 218, 225, 248
Compliance, 18, 21, 47, 61, 181, 188, 214
Cushing’s syndrome, 218, 222, 223
E
Economic evaluation, 202, 241–244
Efferent, 3–6, 11, 12, 14–16, 24, 25, 57–66, 68, 79, 81, 91, 92,
97–100, 109, 110, 131, 161, 172–175, 184
Essential hypertension, 6, 11, 13, 18
Estimated glomerular ltration rate (eGFR), 52, 53, 82, 86, 100, 103,
130, 196, 220, 247, 248
H
Homeostasis, 3–5, 7, 58, 63, 89, 91–93, 97, 108, 110
Hypertension, 21, 79, 89–93, 97–101, 103, 107, 108, 113, 115, 121,
126–129, 133, 149, 152, 153, 156, 171, 181, 193, 199, 209,
229, 237
Hypertension-mediated organ damage, 79, 84, 171, 173, 217
Hypoxia, 108, 110, 193, 195, 198
I
Increased sympathetic activity, 57, 93, 97, 107, 108, 110
K
Kidney-Brain Axis, 5–7
L
Left ventricular hypertrophy, 66, 79, 90, 127, 131, 172
Loin pain hematuria syndrome (LPHS), 125, 126
M
Mapping renal nerves, 182, 183
Mass spectrometry, 230–232
Metabolic diseases, 89
Microneurography, 11–13, 60, 172
N
Non-adherence, 90, 92, 199, 204, 229, 232, 234
Noradrenaline spillover, 11, 13, 16, 59–60, 63, 64
O
Obstructive sleep apnea, 90, 92, 107–110, 214, 218, 223, 225, 248
D
Decision-making tool, 241
Denervation, 14, 15, 21, 23, 25, 37–39, 47, 81, 90, 119, 131, 151, 155,
173, 201, 209, 232–233, 238, 241, 250
Device-based treatments, 199, 204
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023
R. R. Heuser et al. (eds.), Renal Denervation, https://doi.org/10.1007/978-3-031-38934-4
P
Pathophysiology, 3–8, 13, 47, 57, 58, 65, 69, 126, 171, 173, 249
Patient preference, 237–239, 250, 251
Patient selection, 18, 38, 61, 67, 181, 186, 195, 209, 213–214,
248–249, 251
255
256
https://t.me/medicina_free
Index
Pharmacotherapy, 89, 90, 187, 219, 234, 237–239, 249, 250
Pheochromocytoma, 218, 224
Primary aldosteronism (PA), 218, 220
Procedure, 3, 7, 11, 14–16, 18, 21, 22, 26, 38, 39, 41, 42, 47, 48, 60,
61, 63–65, 67–69, 83, 90, 91, 103, 107, 108, 115, 120–122,
133, 143, 149, 182, 187, 188, 194–197, 201–203, 209,
211–214, 218, 233, 238, 244, 247–251
Pulse wave velocity, 41, 84, 85, 213, 248
R
Radiofrequency, 7, 8, 14, 15, 26–29, 34, 37, 40, 42, 47, 49, 54, 62, 63,
108, 115, 119, 130, 133, 136, 152, 160, 167, 173–175, 181,
210, 247
Randomized trials, 103, 135, 136, 212
Renal artery, 6–8, 14–15, 18, 22–24, 29, 31–34, 39–42, 47, 53, 54, 58,
62, 99, 114, 121, 122, 126, 130, 131, 133, 135, 143–149,
151–153, 155–167, 173–175, 182–184, 188, 210–212,
218–220, 250
Renal artery anatomy, 14, 16, 18, 145, 162, 175, 212
Renal denervation, 3, 11, 21, 37, 47, 57, 65, 79, 90, 97, 109, 114, 119,
125, 152, 156, 160, 172, 181, 183, 194, 209, 217, 219, 221,
223, 225, 230, 237, 241, 247, 250
Renal efferent and afferent nerves, 173
Renal failure, 107, 126–128, 202
Renal mapping/ selective system, 183, 187
Renal nerve activity, 3, 5, 6, 62, 63, 132, 173
Renal nerve histology, 14
Renal nerves, 3–8, 14–16, 23, 57–59, 61–64, 68, 83, 97–99, 101, 103,
109, 110, 131, 135, 173, 174, 182, 184, 187, 194
Renal stimulation, 183–186, 188
Renin-angiotensin system, 4, 59, 60, 64, 86, 98, 99, 128, 217
Renovascular hypertension, 99, 218–220
Resistant hypertension, 16, 57, 82, 93, 100, 107–110, 114, 167, 172,
195, 199, 209, 217, 225, 232, 248
Responders, 61, 84, 181, 195, 201, 202, 209–213, 251
S
Secondary hypertension, 217–219, 222, 225
Selective sympathetic denervation, 188
Sensory, 3–8, 11, 14–16, 25, 63, 64, 91, 92, 97, 98, 127, 131, 133,
157, 172–174
Sham-controlled studies, 47, 49, 204, 247
SMART Study, 187–189
Strategy, 18, 39, 61, 63, 90, 92, 93, 120, 128, 143, 211, 237, 239,
241–243, 250
Surrogate endpoints, 65
SyMap, 63, 186–188
Sympathetic, 3, 7, 11, 12, 22, 47, 58–61, 64, 83, 89–92, 98, 100, 108,
113, 119, 156, 171, 182, 183, 195, 209, 249
Sympathetic activation, 13, 15, 16, 18, 59, 81, 83, 89, 91, 92, 101,
108, 109, 172
Sympathetic denervation, 21, 28, 34, 90, 91, 103, 108, 110, 113–115,
119–121, 156, 157, 159, 166, 181–183, 187
Sympathetic nerves, 3, 11, 12, 24, 57, 62, 97–99, 108, 131, 149, 155,
156, 172, 173, 175, 183, 184
Sympathetic nervous system, 6, 7, 11–16, 18, 47, 58, 60, 80, 82, 89,
92, 97–98, 101, 103, 110, 113, 115, 171, 193, 199, 202,
204, 212, 225, 248
Sympathetic nervous system activity, 11–16, 18, 101, 225
T
Transurethral renal nerve ablation, 174
Tricks, 141–149
U
Ultrasound, 7, 8, 26, 31, 32, 34, 39, 40, 42, 43, 47, 49, 54, 62, 127,
128, 130, 133, 149, 151–153, 156, 161, 173, 181, 196, 210,
211, 213, 214, 219, 220, 225, 248
Ultrasound-based devices, 47
Uncontrolled hypertension, 18, 21, 47, 49, 54, 103, 114, 135, 160,
162, 173–175, 187, 188, 195, 196, 229, 241, 250
V
Ventricular arrhythmias, 68, 93, 119–121
Ventricular brillation (VF), 68, 120
Ventricular tachycardia, 68, 113, 119–121
Соседние файлы в папке Библиотека им академика М.И. Перельмана